Tuesday, August 18, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
Business & M&AAllergan Adds Quarterly Botox Rebate for GrowthtodayDevices & TechApyx: GLP-1 Boom Is Fueling Renuvion Demand2 days agoRegulatoryGalderma Wins EU Nod for Restylane ShaypetodayInjectablesHugel Posts Record H1 on Toxin Surge—Overseas Growth Accelerates2 days agoComplianceWarning: Unauthorized Injectables Seized in CanadatodayBusiness & M&AEvolus Posts Break-Even Q2—Path to Sustained Profit Clear2 days agoBusiness & M&ARejuran Maker PharmaResearch Acquires Cosmetic GrouptodayInjectablesAbbVie's Botox Sales Surge—What's Driving the RevivalyesterdayInjectablesMOLD Manila Rolls Out Radiesse for Facial RejuvenationyesterdayRegulatoryBOTOX Masseter Indication Moves Closer to FDA OKyesterdayBusiness & M&AAllergan Aesthetics Refreshes APP Loyalty ProgramyesterdayDevices & TechFDA Clears Ultherapy PRIME for Knee Skin Laxityyesterday
1 free article left this week. A free account gets you 4 a week.Go Pro →
Business & M&A

Allergan Adds Quarterly Botox Rebate for Growth

New rebate structure ties incentives to volume milestones—a shift in how the company rewards loyalty.

Image: Inside MedSpa
1-YEAR MOVE
+15% −41%
ABBV ▲11.6% EOLS ▼15.6%
1-year price move by ticker
TickerCompany1-year change
ABBVAbbVie (Allergan Aesthetics)+11.6%
EOLSEvolus−15.6%

Allergan Aesthetics has introduced a quarterly rebate mechanism for Botox tied to qualifying growth thresholds, layering a new incentive tier onto its existing Partner Privileges loyalty program. The structure rewards practices that hit volume targets within each quarter, creating a more granular path to rebates than traditional annual models.

Quarterly rebates create faster cash-back cycles but demand tighter volume forecasting.

This move signals Allergan's tighter focus on volume retention amid competitive pressure from Evolus and Revance. Quarterly resets also allow the company to adjust targets dynamically—a tactical advantage in a market where practices are increasingly price-sensitive and willing to shift toxin allegiance. For owners, the math matters: hitting quarterly thresholds can unlock cash back faster than waiting for year-end reconciliation, but it also requires tighter inventory management and forecasting.

Source: original report ↗

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/allergan-adds-quarterly-botox-rebate-growth/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo